01167.HK香港交易所 · 主板 MainBPre-revenue biotech (Listing Rules ch.18A)
Jacobio 加科思
Pharmaceuticals and Biotechnology 药品及生物科技
HK$5.83−HK$0.13 · −2.26%
Open 开盘
HK$6.17
High 最高
HK$6.17
Low 最低
HK$5.77
Prev Close 昨收
HK$5.97
Volume 成交量
35.4万股
Turnover 成交额
HK$208.6万
Mkt Cap 总市值
HK$46亿
P/E 市盈率
−28.2×
Recent Activity 近期动态All Filings 全部公告 →
One significant filing since 31 May 2026, on management change (24 Aug 2026): 截至2026年6月30日止六个月的中期业绩公告及委任副董事长及高级管理层变动.
自 31 May 2026 起有一份重大公告（management change，24 Aug 2026）：截至2026年6月30日止六个月的中期业绩公告及委任副董事长及高级管理层变动。
Price History 价格走势
1 session 个交易日, Mon 28 Sep 2026 · Live one-minute prices · High 最高 HK$6.17 · Low 最低 HK$5.78 · −2.26% on the previous close of HK$5.975.805.906.006.10
09:3009:5710:2410:5011:17
Substantial Shareholders 主要股东
Interests of 5% or more disclosed to HKEX under Part XV of the SFO · 10 largest of 20 · Stake as % of issued voting shares of the class 该类别已发行有投票权股份
Several holders often report the same shares, so the stakes do not add up. 多名股东常就同一批股份申报，持股比例不可相加。
35.92%
35.92%
ULTIMATE ESTATE LIMITED
Institution 机构
2.11亿股 · As of 截至 26 Jan 2024
26.67%
TREASURE PARTNER INTERNATIONAL LIMITED
Institution 机构
2.11亿股 · As of 截至 26 Jan 2024
26.67%
26.67%
25.28%
25.28%
25.28%
Gloryviewpharma Ltd
Institution 机构
2.00亿股 · As of 截至 18 Sep 2025
25.28%
Yakovpharma Ltd
Institution 机构
2.00亿股 · As of 截至 28 Apr 2025
25.21%